Abbott’s Kaletra Gets FDA Warning for Causing Health Problems in Babies
The FDA is ordering a label change for Abbott’s HIV drug Kaletra (lopinavir/ritonavir) to warn of serious health problems reported in premature babies after receiving the oral solution preparation of the medicine.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.